echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Enzyme Technology > Autophagy: autophagy of dendritic cells can improve their anticancer activity

    Autophagy: autophagy of dendritic cells can improve their anticancer activity

    • Last Update: 2019-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    May 22, 2019 news / BIOON / - autophagy contributes to cell homeostasis Recently, it has been reported that autophagy has another function KAIST's team found that autophagy of dendritic cells supports the antitumor activity of T cells Autophagy is a process of maintaining cell homeostasis by removing waste and damaged organelles; however, its role in phagocytosis of tumor associated antigen expression is still unclear Photo source: autophagy at the same time, dendritic cells are cells that recognize pathogens or cancer antigens and induce immune responses in T cells When cancer cells are killed by radiation or anticancer drugs, dendritic cells absorb and remove them, present antigens on the surface, and transfer them to T cells Professor Heung kyu Lee of the Graduate School of medical science and engineering and his team found that autophagy of dendritic cells plays a key role in T cell activation, and they proposed the principle of enhancing the anti-cancer effect Their experiments show that when dendritic cells lack ATG5 (autophagy related gene), the activation of T cells and the anti-cancer immune response will decrease Interestingly, atg5-deficient dendritic cells significantly increased the cell surface receptor CD36, increased the phagocytosis of apoptotic tumor cells, but limited the activation of T cells At this time, in order to block the receptor CD36, when introducing antibodies into the system, the response of anti-tumor T cells increased significantly, while the tumor growth decreased Professor Lee said: "this study enables us to explore the role of autophagy in the anti-cancer immune response of T cells We are looking forward to using CD36 receptor to develop targeted anticancer therapy "The study was published in the journal autophagy Reference: Dong sun Oh et al Autohagy protein ATG5 regulates CD36 expression and anti tumor MHC class II antigen presentatio in dendritic cells, autohagy (2019) Doi: 10.1080/15548627.2019.1596493
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.